Hereditary spastic paraplegia initially diagnosed as cerebral palsy

Oksana Suchowersky1, Setareh Ashtiani2, Ping-Yee Billie Au2

  • 1University of Alberta, Departments of Medicine (Neurology) and Medical Genetics, Edmonton, Canada.

Insights

Many children with hereditary spastic paraplegia (HSP) are initially misdiagnosed with cerebral palsy (CP). Early spastic diplegia in infants warrants consideration of HSP for accurate diagnosis, prognosis, and management.

Area of Science:

  • Neurogenetics
  • Pediatric Neurology

Background:

  • Spastic diplegia in infancy is a common presentation for both cerebral palsy (CP) and hereditary spastic paraplegia (HSP).
  • Distinguishing between CP and HSP in early childhood can be challenging.
  • This study investigates a cohort of patients initially diagnosed with CP who were later identified as having HSP.

Purpose of the Study:

  • To identify the clinical and genetic features of hereditary spastic paraplegia (HSP) in a cohort of patients initially diagnosed with cerebral palsy (CP).
  • To evaluate the diagnostic yield of whole exome sequencing (WES) in these cases.
  • To highlight the importance of considering HSP in infants presenting with spastic diplegia.

Main Methods:

  • Chart review of 14 patients from an Alberta registry of HSP patients with an initial CP diagnosis.
  • Whole exome sequencing (WES) was performed to identify genetic causes.
  • Analysis of clinical presentation, symptom progression, and family history.

Main Results:

  • Of 90 families with pediatric spasticity, 14 initially received a CP diagnosis.
  • Whole exome sequencing identified pathogenic mutations in six genes (ATL1, PLP1, PNPLA6, SACS, SPAST, SYNE1) in nine cases.
  • In five families, WES was inconclusive, but symptom progression and family history suggested HSP.

Conclusions:

  • Approximately 70% of HSP cases presenting with spasticity under three years of age were misdiagnosed as CP in this cohort.
  • HSP should be considered in young children with spastic diplegia, especially without clear risk factors like prematurity or infection.
  • Accurate diagnosis of HSP is crucial for appropriate prognosis, management strategies, and genetic counseling regarding recurrence risk.
Abstract

Related Concept Videos

Parkinson's Disease: Overview01:15

Parkinson's Disease: Overview

Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
820